Bolt Biotherapeutics, Inc. Stock Prediction and Forecast [BOLT]

AI-generated source summary

Bolt Biotherapeutics (BOLT) shows mixed signals with positive short-term indicators but a prevailing downward trend. While recent insider buying and positive short-term technical signals suggest a potential buying opportunity, the stock's overall performance and medium-term outlook, as indicated by RSI and analyst ratings, lean bearish. The stock's price action is currently within a descending channel, with key support and resistance levels at $5.31 and $5.66 respectively. A breach below support at $5.24 could signal further downside, while a sustained move above resistance at $5.66 might indicate a trend reversal. The stock has experienced significant daily volatility, contributing to a medium risk profile.

AI-generated summary based on the source content.

Evidence and evaluation progress

1. Original source published

   09 Dec 2025, 04:11 UTC

   The analyst published the original source item.

2. First prediction resolved

   09 Dec 2025, 14:30 UTC

   The first evaluable outcome in this case reached a terminal result.

3. Case evaluation completed

   09 Dec 2025, 14:30 UTC

   All evaluable predictions in this case reached terminal outcomes.

4. Source recorded by Tahlil Plus

   18 May 2026, 20:23 UTC

   The public source was preserved as the evidence record for this case.

5. Market predictions extracted

   18 May 2026, 20:48 UTC

   1 eligible signal linked to this case.

6. Outcome tracking started

   02 Jul 2026, 01:22 UTC

   Tahlil Plus began monitoring the extracted predictions.